141 related articles for article (PubMed ID: 31315058)
1. Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry.
Bouchal P; Schubert OT; Faktor J; Capkova L; Imrichova H; Zoufalova K; Paralova V; Hrstka R; Liu Y; Ebhardt HA; Budinska E; Nenutil R; Aebersold R
Cell Rep; 2019 Jul; 28(3):832-843.e7. PubMed ID: 31315058
[TBL] [Abstract][Full Text] [Related]
2. High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratification.
Azevedo ALK; Gomig THB; Batista M; Marchini FK; Spautz CC; Rabinovich I; Sebastião APM; Oliveira JC; Gradia DF; Cavalli IJ; Ribeiro EMSF
J Proteomics; 2023 Aug; 285():104955. PubMed ID: 37390896
[TBL] [Abstract][Full Text] [Related]
3. Protein Corona Gold Nanoparticles Fingerprinting Reveals a Profile of Blood Coagulation Proteins in the Serum of HER2-Overexpressing Breast Cancer Patients.
Chantada-Vázquez MDP; Castro López A; García-Vence M; Acea-Nebril B; Bravo SB; Núñez C
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182810
[TBL] [Abstract][Full Text] [Related]
4. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
[TBL] [Abstract][Full Text] [Related]
5. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
Anjo SI; Santa C; Manadas B
Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
[TBL] [Abstract][Full Text] [Related]
6. Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics.
Gajbhiye A; Dabhi R; Taunk K; Vannuruswamy G; RoyChoudhury S; Adhav R; Seal S; Mane A; Bayatigeri S; Santra MK; Chaudhury K; Rapole S
Proteomics; 2016 Sep; 16(17):2403-18. PubMed ID: 27324523
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Breast Cancer Protein Biomarkers at Different Expression Levels in Human Tumors.
Chen Y; Britton D; Wood ER; Brantley S; Fournier M; Wloch M; Williams VL; Johnson J; Magliocco A; Pike I; Koomen JM
Methods Mol Biol; 2018; 1788():251-268. PubMed ID: 29243084
[TBL] [Abstract][Full Text] [Related]
8. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.
Arnhard K; Gottschall A; Pitterl F; Oberacher H
Anal Bioanal Chem; 2015 Jan; 407(2):405-14. PubMed ID: 25366975
[TBL] [Abstract][Full Text] [Related]
9. Next Generation Proteomics for Clinical Biomarker Detection Using SWATH-MS.
Lin Q; Tan HT; Chung MCM
Methods Mol Biol; 2019; 1977():3-15. PubMed ID: 30980318
[TBL] [Abstract][Full Text] [Related]
10. Optimization of Acquisition and Data-Processing Parameters for Improved Proteomic Quantification by Sequential Window Acquisition of All Theoretical Fragment Ion Mass Spectrometry.
Li S; Cao Q; Xiao W; Guo Y; Yang Y; Duan X; Shui W
J Proteome Res; 2017 Feb; 16(2):738-747. PubMed ID: 27995803
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Proteomic Analysis of Fresh-Frozen Biopsy Tissue Samples Using Pressure Cycling Technology Coupled with SWATH Mass Spectrometry.
Zhu Y; Guo T
Methods Mol Biol; 2018; 1788():279-287. PubMed ID: 29071490
[TBL] [Abstract][Full Text] [Related]
12. Subtyping of breast cancer using reverse phase protein arrays.
Sonntag J; Schlüter K; Bernhardt S; Korf U
Expert Rev Proteomics; 2014 Dec; 11(6):757-70. PubMed ID: 25400094
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
[TBL] [Abstract][Full Text] [Related]
14. Gaussian Mixture Models for Probabilistic Classification of Breast Cancer.
Prabakaran I; Wu Z; Lee C; Tong B; Steeman S; Koo G; Zhang PJ; Guvakova MA
Cancer Res; 2019 Jul; 79(13):3492-3502. PubMed ID: 31113820
[TBL] [Abstract][Full Text] [Related]
15. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
16. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
19. Label-free proteomic analysis of breast cancer molecular subtypes.
Panis C; Pizzatti L; Herrera AC; Corrêa S; Binato R; Abdelhay E
J Proteome Res; 2014 Nov; 13(11):4752-72. PubMed ID: 25221861
[TBL] [Abstract][Full Text] [Related]
20. SWATH enables precise label-free quantification on proteome scale.
Huang Q; Yang L; Luo J; Guo L; Wang Z; Yang X; Jin W; Fang Y; Ye J; Shan B; Zhang Y
Proteomics; 2015 Apr; 15(7):1215-23. PubMed ID: 25560523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
